chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient was admitted to the hospital through the emerge apart with shortness of breath.  He is found to have an acute exacerbation of diastolic CHF Covid 19 pneumonia and acute COPD exacerbation.  He was treated with antiviral medicine the steroids anticoagulants diuretics.  He made slow clinical improvement.  He was discharged home in improved condition.  Discussed continued isolation precautions at home.
Initial misuse report received from a helathcare professional (nurse) on 24 October 2013 and the case was received on 21 March 2014. A 15.month-old patient (gender was not reported) has received only the DTap-IPV portion of PENTACEL (batch number, route and site of administration was not reported), however the ActHIB component was not administered on an unspecified date. No adverse event was reproted. List of documents held by sender: none
I awoke at 1:30am 0n Tuesday April 27th shaking with chills, headache and fever that went up to 100.7.  I had received the second Moderna shot 16 hours before at 9:30am the previous morning (Monday April 26th 2021).  I had chills and shaking until noon but had the headache and some aches in my arms and legs until about midnight when I fell asleep for the night. I woke up on Wednesday April 28th at 5am exhausted but no aches, headachce or chills.  I am just taking it easy today and try and recoup my strength.
Severe localized swelling, erythema, and tenderness.  Associated Headache and diarrhea.  She received PPSV23 in the contralateral arm the same day.
This spontaneous report as received from a registered nurse refers to a 13 year old patient of unknown gender. Patient's concurrent conditions and relevant medical history was unknown. On 26-AUG-2014 the patient was vaccinated with GARDASIL (dose and route unspecified) (lot number: J010668 with expiry date of 29-APR-2016) in the left arm. Concomitant medications were unknown. The nurse stated that refrigerator temp were out of range from 19-AUG-2014 to 26-AUG-2014. All vaccines were viable. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with GARDASIL was not reported. This is one of the several reports from the same reporter. Additional information has been requested.
Symptoms on Friday 9-16, had fever, achy, fatigue, X 1 1/2 days. Left arm swelling with redness, soreness unable to sleep on throat side. Other left upper arm warm to touch, erythema approximately 13cm X 10cm tender to touch.
Information has been received from a physician concerning a 65 year old male pt with coronary artery disease, congestive heart failure, type II diabetes, and kidney stones and a history of gastric banding who on 10/17/06 was vaccinated on left shoulder with his first dose of Pneumococcal 23v polysaccharide vaccine (lot 651322/1044P). The pt also received influenza virus vaccine on the right shoulder. Concomitant therapy included Altace, Elavil, Lasix, potassium, Coreg and Keflex. Within 3 hours the pt had localized pain left arm and shivering. An hour later he had sluggish speech, was confused, and was taken to the ER with a systolic blood pressure of 129 and sat oxygen of 100%. He was confused, and slurred speech, and severe shivering. Warm blanket and oxygen administered. The pt had severe left shoulder pain, especially with movement, with a heavy sensation in arm. The physician indicated that blood tests including cardiac enzymes were performed, and that the events did not appear to be cardiac related. The pt was not able to raise his arm but was able to move his fingers, there was severe pain with passive movement of arm. Additional vital signs included systolic blood pressure 109, pulse 55, temp 97.7. The physician stated that he may need to transfer the pt to a larger facility for treatment, evaluation, and possible admission. The reporter also indicated that previous doses of influenza virus vaccine have not resulted in adverse symptoms. the physician considered the events to be immediately life threatening, and other important medical events (OMIC). A product quality complaint was not involved. Additional information has been requested.
pt recv vax 13JUN95 & 15JUN95 pt devel a small red, raised, rough rash on face & neck; No further details were provided;
Patient had his 2nd Moderna Covid Vaccine on 1/6/21...it was a day after a colonoscopy.  He had a normal bowel movement 1/7/21 but has only had watery diarrhea since. He has tried pepto bismol and immodium to no avail.
At the time of administering the vaccine ID the client suddenly moved - jerking his arm away.  Vaccine was seen running down patients arm so full dose was not given.  Successfully re- administered on same arm using sub-cut method.
Felt feverish/chills, body aches, cough, fatigue, generalized headache, nausea, vomiting, sore throat, decreased appetite, arm is sore.
Nausea for the first month.  June 16th started experiencing tightness in my left shoulder, then heart pain, then numbness in my left arm.  These symptoms lasted until October 1st.
After approximately a week?s time and after a workout at the gym, I noticed my arm hurt to raise it above my head. I observed a reddened fibrous cord-like area from my axilla to just above the inside of my elbow. Very painful initially. After stretches, massaging, and apply warmth, pain is nearly gone yet cord is still visible and slightly painful. Dr?s appt revealed one enlarged lymph node in same axilla.
itching on a previous scar; pain from the xifoid to her back; burning in the arm; joint pain; head ache; This spontaneous case was reported by a  and describes the occurrence of PAIN (pain from the xifoid to her back), VACCINATION SITE PAIN (burning in the arm), ARTHRALGIA (joint pain), HEADACHE (head ache) and PRURITUS (itching on a previous scar) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (pain from the xifoid to her back), VACCINATION SITE PAIN (burning in the arm), ARTHRALGIA (joint pain), HEADACHE (head ache) and PRURITUS (itching on a previous scar). At the time of the report, PAIN (pain from the xifoid to her back), VACCINATION SITE PAIN (burning in the arm), ARTHRALGIA (joint pain) and HEADACHE (head ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
mom states child c/o lt neck pain & lt flank pain & side pain;BP 455PM 11AUG98 BP 130/84 child pale & lethargic (had a capsule of DPH 930AM 11AUG98 none since)
Pericarditis- extreme chest pain that did not go away for 12 hours, went to emergency room
Information has been received from a emergency medical technician concerning a 19 year old patient who was vaccinated with a MMR II and had negative titers to measles. This is one of several reports from the same source. Additional information has been requested.
Very sore arm, sore elbow in arm where received injection, chills, fever, nausea, brief vomiting, sweating
Right arm: swollen, red, hot, hard, pain and  fever for 48 hrs
Saturday 30 minutes after administration  patient felt nausea lethargy and stiff neck and back.  Next morning Sunday patient woke with a fever of 99.6 and large blood clot in mouth.  Two days post vaccine Monday patient work with large blood clot on pillow.  That evening patient had 2 more blood clots spontaneously coming from teeth.  Tuesday morning upon arising from chair pt experienced an intense metallic taste.  Patient then experienced several 8 mouth fulls of blood on 3 occasion in same evening.  Patient states it was pushing out from gums.
Severe headache, nausea and cold sensation occurred within a few hours of receiving the vaccine.  Arm discomfort and fatigue quickly followed.  Low grade fever noted approximately 8 hours post vaccine.   I took acetaminophen.  Headache, fatigue, and fever/chills resolved within about 48 hours.  Nausea and arm discomfort persisted for about 5 days.   After approximately 48 hours, I noted vision changes, blurry up-close vision.  This change might have occurred sooner, but it was not until this time that I felt well enough to really read.  The change in vision led me to seek further evaluation in the emergency room on 1/16/2021.
Vaccine causing incontinence; dribble; This spontaneous case was reported by a consumer and describes the occurrence of INCONTINENCE (Vaccine causing incontinence) and URINARY INCONTINENCE (dribble) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCONTINENCE (Vaccine causing incontinence) and URINARY INCONTINENCE (dribble). At the time of the report, INCONTINENCE (Vaccine causing incontinence) had not resolved and URINARY INCONTINENCE (dribble) outcome was unknown. Not Provided          No concomitant medications were provided by reporter. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received on 28 Jul 2021: Added new event
itchy at injection site; little red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (little red at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (little red at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (little red at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
3 swollwn lymph nodes on her neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (3 swollwn lymph nodes on her neck) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Thyroid cancer.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced LYMPHADENOPATHY (3 swollwn lymph nodes on her neck). At the time of the report, LYMPHADENOPATHY (3 swollwn lymph nodes on her neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Generalized seizures. The ER record received on 2/19/04 states bilateral aspiration pneumonia.
Next stiffness, cannot turn head. Pain when swallowing, swollen lymph nodes in neck headache, congestion.
pt suffered sz & fever 103 approx 3hrs p/vax; ER visit & hospitalized;
Worsening severe sharp constant LLQ abdominal pain radiating to the RLQ and nausea. Hurts when she eats and with activity and nothing makes it better. Also presented with fever to 102.3 F. Thought to be possible appendicitis, but appendix not removed.
Narrative:  COVID infection after completion of COVID vaccine series: 04/08/2021 COVID vaccine dose #1 05/04/2021 COVID vaccine dose #2 07/15/2021 Pt reported onset of rhinorrhea, nasal and chest congestion, minor HA, and productive cough 07/17/2021 COVID positive per nasopharyngeal swab. Pt prescribed abx and allergy meds plus supportive care. 07/18/2021 Pt reported onset of chills, fever, fatigue, diarrhea, myalgia, loss of sense of taste/smell, N/V, and sore throat 07/19/2021. Pt reported improvement of chills, fever, HA, and sore throat. Continuation of cough and diarrhea. 07/20/2021 Pt reported continuation of sx 07/21/2021 Pt reported improvement of cough, N/V, and sense of taste/smell. Continuation of diarrhea, but staying hydrated. 07/22/2021 Pt reported feeling fatigues 07/23/2021 Pt reported continued rhinorrhea and fatigue. Self-medicating as recommended. 07/24/2021 Pt reported continued rhinorrhea and fatigue. Self-medicating as recommended.
m my arm is sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (m my arm is sore at the injection site) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event reported).    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced INJECTION SITE PAIN (m my arm is sore at the injection site). At the time of the report, INJECTION SITE PAIN (m my arm is sore at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.        No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
A consumer report has been received. The report concerns a 2 year old Male consumer, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. At the time of reporting, the event of fever was ongoing. The report was considered to be non-serious by the reporter.
did not feel good; she saw a body rash this morning. However, when attempted to confirm event she confirmed as body rush.; had a very high heartbeat, heartrate, then everything was gone; This is a spontaneous report from a contactable consumer or other non hcp. A 54-years-old female patient received bnt162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: ER8730, Expiration date: Jul2021) via an unspecified route of administration, in right arm on 29Mar2021 at 09:00 as first dose, single for COVID-19 immunization (Age at vaccination 54 years). Medical history and family medical history relevant to AE were reported as none. No prior vaccinations (within 4 weeks) were reported. No additional vaccines were administered on same date of the Pfizer suspect. There were no concomitant medications reported. On an unspecified date, the patient just did not feel good. On 29Mar2021, patient reported that she had 2 reactions, when the vaccine was done, for next 10 minutes she had a very high heartbeat, heartrate, then everything was gone. On 30Mar2021, when patient woke up, she saw a body rash this morning however, when attempted to confirm event she confirmed as body rush. It was reported that high heartbeat started probably sometime between 9:00-9:10 AM and it occurred like ten minutes after getting the vaccine. The patient underwent lab tests which included heart rate: very high on 29Mar2021, heart rate increased: very high on 29Mar2021. Events did not require visit to Emergency room or physician Office visit. She remarked that at least at the time of reporting, she did not have to go to an EM or physicians office. Stated right now, she just did not feel good. Patient wanted to report a reaction after the vaccine and wanted to know if it would be ok to get the second dose and if it was possible to have worse reaction if you have little reaction. She has heard that the second dose can have a worse effect that the first because body has it, she was just wondering. The outcome of event heart rate increased was recovered on an unspecified date in 2021, outcome for events rash was not recovered while the event patient just did not feel good was unknown.  No follow-up attempts are possible. No further information is expected.
On 10/26/2021 I woke up around 08:00-08:30 and my entire body ached, and I could barely walk. I laid around the house and took OTC ibuprofen. I didn't feel like doing anything and I did not contact my PCP. I was totally miserable for 24hrs and then it eased up a little bit. But I did have an increase in pain for several days. Every now and again, it flares up and my joints and muscles ache. No rhyme or reason or pattern. It feels like I have been hit by a truck. I have told my doctor a little bit about it, but he hasn't really done anything. I do have my routine labs every three months, and nothing has been unusual. Most of my high numbers were because I am Diabetic. There wasn't anything we hadn't seen in the past.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced a case of Shingles after receiving SHINGRIX. The pharmacist stated he was off work the day of reporting and was unable to provide further details regarding the event. He provided the pharmacy mailing address as noted in mailing address details.
Numbness and tingling down left arm and in pinky and rink finger, extreme pain at injection site, weakness in left arm, tightness in elbow, all signs of ulnar neuropathy that appeared within 15 minutes after injection
Information has been received from a registered nurse concerning a patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23 (lot # not reported). Subsequently the patient experienced significant arm swelling after administration of vaccine. The patient sought a medical attention by phone or office visit. The outcome was unknown at the time of this report. No further information is available.
Arm red and warm to the touch extending all the way to the elbow, some itching that was relieved with BENADRYL.
Patient's son (a DMD) is visiting from out of time and noticed that his mother had a raised area on her arm that he found out was the injection site.  It has just become raised, and is warm to the area. Last evening (01/09) it was also itchy.
Started with  a bright aura which turned in nausea and vomiting  around 15 minutes later then started a severe migraine immediately after (I do have history of migraines this was the worst I have had in 5 years).  I had blurry vision, dizziness, pain down the back of the head into the neck.  I got chills and body aches.  I was sensitive to light and sound. This all occurred over 22 hours. I took Imitrex 100 mg two times.  I slept for 22 hours.. I woke up around 8 hours into the 22 hour mark to call off work and take Imitrex.   I woke up feeling like I was run over by a truck. after 22 hours.  The next day I worked a half day and was exhausted.  I had the next 2 days off and I had to rest those days to get my energy back
Moderna Covid 19 Vaccine EUA  Woke up 3/6/21 with drippy left eye and runny nose nothing else until Sunday afternoon 3/7/21 noticed droopy left eye, cheek and mouth. We to hospital ER for stroke protocol. Dr diagnosed BellsPalsy and not stroke. Advised me to contact a neurologist. Received prescription  for Prednisone
Patient was given a high dose flu vaccine in error. No complaint of symptoms or treatment needed on follow-up.
received and expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received Men B NVS (Bexsero) (batch number unknown, expiry date 31st October 2021) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe (batch number unknown, expiry date 31st October 2021) for prophylaxis.   On 1st November 2021, the patient received Bexsero. On an unknown date, the patient started Bexsero Pre-Filled Syringe Device. On 1st November 2021, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: Age at vaccination were not reported. Medical Assistant reported that a patient received an expired dose of Bexsero. The reporter did not consent to follow-up.
after 1 minute light headed only lasted for about 20 seconds then went away. About 30 minutes later some. Mild chest pain in the center of chest. Lasted  about 30 seconds. 4hr later fever and ill-feeling lasted about an hour and subsided. Then came back about 2 hours later then subsided after about 3-4 hrs with some pain at injection site in the arm. Had on and off fever and ill-feeling that would come and go throughout the entire day lasting 2 to 4 hours at a time. That went on for 6-7 days. Then I felt fine. Injection site arm sore for about 4 days after that I was fine.
Per EMR, patient received one dose of Pfizer COVID19 vaccine on 3/18/21. No documentation that patient received second dose. Patient admitted to hospital on 9/2/21 and incidentally was found to be positive for COVID19 as it was not what lead to the patient's admission. Per progress note on admission, patient had minimal  complaints regarding symptoms related to COVID 19. Patient was isolated to "COVID unit" for admission.
lack of efficacy- contracted COVID-19; lack of efficacy- contracted COVID-19; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular administered in Arm Right on 05Feb2021 (Lot Number: EM9810) at age of 39-year-old, dose 2 intramuscular administered in Arm Right on 24Feb2021 (Lot Number: EN6202) at age of 39-year-old, both at single dose for covid-19 immunisation.  Medical history included asthma. No covid prior vaccination.   There were no concomitant medications. The patient previously took cefaclor (CECLOR) and experienced drug hypersensitivity. No other vaccine in four weeks. The patient experienced lack of efficacy- contracted covid-19 on 16Aug2021. Events resulted in [Doctor or other healthcare professional office/clinic visit]. No treatment received. The patient underwent lab tests and procedures which included sars-cov-2 test (Rapid Nasal Swab): positive on 25Aug2021.  The outcome of events was recovering.  Follow-up attempts are completed. No further information is expected.
Information has been received from a health care provider concerning patients who were vaccinated with Rotateq. The health care provider reported that on an unspecified date multiple patients may have received Rotateq which had been improperly stored vaccine since FEB-2007. No problems reported. The patients sought unspecified medical attention. Additional information has been requested.
Severe itching and hives over entire body within 45 minutes of dose. Benadryl and Solu-medrol administered IV.
The next day the patient developed a warm, raised area about 1.5 -2 inches below her vaccination site on her left arm. She states it is painful.
Brief episode of chest pain 5 hours post-vaccination, resolved in 20 minutes. Early morning episodes of vertigo, severe enough to awaken and nauseate me.
3days p/vax pt devel erythema multiforme, became jaundiced, & was hosp on 7/19; pt remained hosp due to elevated liver function tests